Resultats globals: 56 registres trobats en 0.01 segons.
Articles, 35 registres trobats
Llibres i col·leccions, 2 registres trobats
Documents de recerca, 19 registres trobats
Articles 35 registres trobats  1 - 10següentfinal  anar al registre:
1.
17 p, 921.2 KB Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes / Sauta, Elisabetta (Humanitas Clinical and Research Center (Itàlia)) ; Robin, Marie (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis (França)) ; Bersanelli, Mateo (Department of Biomedical Sciences. Humanitas University) ; Travaglino, Erica (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Meggendorfer, Manje (Mll Munich Leukemia Laboratory) ; Zhao, Lin-Pierre (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis (França)) ; Caballero Berrocal, Juan Carlos (Hematology Department. Hospital Universitario de Salamanca) ; Sala, Claudia (Experimental. Diagnostic and Specialty Medicine. Dimes) ; Maggioni, Giulia (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Bernardi, Massimo (University Vita-Salute San Raffaele (Itàlia)) ; Di Grazia, Carmen (Irccs Ospedale Policlinico San Martino) ; Vago, Luca (University Vita-Salute San Raffaele (Itàlia)) ; Rivoli, Giulia (Irccs Ospedale Policlinico San Martino) ; Borin, Lorenza (Ospedale San Gerardo) ; D'Amico, Saverio (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Tentori, Cristina Astrid (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Ubezio, Marta (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Campagna, Alessia (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Russo, Antonio (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Mannina, Daniele (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Lanino, Luca (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Chiusolo, Patrizia (Università Cattolica Del Sacro Cuore) ; Giaccone, Luisa (Department of Molecular Biotechnology and Health Sciences. University of Turin) ; Voso, Maria Teresa (Tor Vergata University) ; Riva, Maria (Asst Grande Ospedale Metropolitano Niguarda) ; Oliva, Esther Natalie (Grande Ospedale Metropolitano Bianchi Melacrino Morelli) ; Zampini, Matteo (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Riva, Elena (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Nibourel, Olivier (Chu Lille) ; Bicchieri, Marinela (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Bolli, Niccolo (Department of Oncology and Hemato-Oncology. University of Milan) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni Xxiii) ; Passamonti, Francesco (Department of Medicine and Surgery. University of Insubria) ; Savevski, Victor (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Santoro, Armando (Department of Biomedical Sciences. Humanitas University) ; Germing, Ulrich (Department of Hematology. Heinrich-Heine-University. University Clinic) ; Kordasti, Shahram (Hematology Department. DISCLIMO-Università Politecnica Delle Marche) ; Santini, Valeria (University of Florence) ; Diez-Campelo, María (Hospital Universitario de Salamanca) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Sole, F (Institut de Recerca Contra la Leucèmia Josep Carreras) ; Kern, Wolfgang (Mll Munich Leukemia Laboratory) ; Platzbecker, Uwe (University Hospital Leipzig) ; Arenillas, Leonor (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis) ; Fenaux, Pierre (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis) ; Haferlach, Torsten (Mll Munich Leukemia Laboratory) ; Castellani, Gastone (Experimental. Diagnostic and Specialty Medicine. Dimes) ; Della Porta, Matteo Giovanni (Department of Biomedical Sciences. Humanitas University)
PURPOSEMyelodysplastic syndromes (MDS) are heterogeneous myeloid neoplasms in which a risk-adapted treatment strategy is needed. Recently, a new clinical-molecular prognostic model, the Molecular International Prognostic Scoring System (IPSS-M) was proposed to improve the prediction of clinical outcome of the currently available tool (Revised International Prognostic Scoring System [IPSS-R]). [...]
2023 - 10.1200/JCO.22.01784
Journal of Clinical Oncology, Vol. 41 Núm. 15 (20 2023) , p. 2827-2842  
2.
13 p, 1.6 MB Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8 / Toribio-Castelló, Sofía (CIBERONC. Research Group CB16/12/00233) ; Castaño-Díez, Sandra (Hospital Clínic i Provincial de Barcelona) ; Villaverde-Ramiro, Ángela (Universidad de Salamanca) ; Such, Esperanza (Hospital Universitari i Politècnic La Fe (València)) ; Arnan, Montserrat (Hospital Duran i Reynals (Hospitalet del Llobregat)) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Díaz-Beyá, Marina (Hospital Clínic i Provincial de Barcelona) ; Díez-Campelo, María (CIBERONC. Research Group CB16/12/00233) ; del Rey, Mónivs (Hospital Universitario de Salamanca) ; González, Teresa (Hospital Universitario de Salamanca) ; Hernández-Rivas, Jesús María (CIBERONC. Research Group CB16/12/00233)
Trisomy 8 (+8) is the most frequent trisomy in myelodysplastic syndromes (MDS) and is associated with clinical heterogeneity and intermediate cytogenetic risk when found in isolation. The presence of gene mutations in this group of patients and the prognostic significance has not been extensively analyzed. [...]
2023 - 10.3390/cancers15153822
Cancers, Vol. 15 Núm. 15 (august 2023) , p. 3822  
3.
12 p, 801.4 KB The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw / Calvete, Oriol (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mestre, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Jerez, Andrés (Vall d'Hebron Institut d'Oncologia) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. [...]
2023 - 10.3390/cancers15051483
Cancers, Vol. 15 Núm. 5 (march 2023) , p. 1483  
4.
10 p, 1.3 MB Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms / Calvete, Oriol (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mestre, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Risueño, Ruth M. (University of Atlántico Medio, Las Palmas) ; Manzanares Mileo, Ana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Acha, Pamela (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Next-generation sequencing (NGS) tools have importantly helped the classification of myelodysplastic syndromes (MDS), guiding the management of patients. However, new concerns are under debate regarding their implementation in routine clinical practice for the identification of germline predisposition. [...]
2023 - 10.3390/biomedicines11123222
Biomedicines, Vol. 11 Núm. 12 (december 2023)  
5.
30 p, 7.3 MB Single-Cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy / Campillo-Marcos, Ignacio (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Casado Pelaez, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Davalos, Veronica (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ferrer, Gerardo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mata, Caterina (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mereu, Elisabetta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Roué, Gaël (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ; Molero, Antonieta (Hospital Universitari Vall d'Hebron) ; Zamora, Lurdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Palomo Sanchís, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Acha, Pamela (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Manzanares Mileo, Ana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tobiasson, Magnus (Karolinska Institutet (Estocolm, Suècia)) ; Hellström-Lindberg, Eva (Karolinska Institutet (Estocolm, Suècia)) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Alterations in epigenetic marks, such as DNA methylation, represent a hallmark of cancer that has been successfully exploited for therapy in myeloid malignancies. Hypomethylating agents (HMAs), such as azacitidine (AZA), have become standard-of-care therapy to treat myelodysplastic syndromes (MDS), myeloid neoplasms that can evolve into acute myeloid leukemia (AML). [...]
2024 - 10.1158/2767-9764.CRC-23-0389
Cancer Research Communications, Vol. 4 Núm. 2 (2024)  
6.
4 p, 551.6 KB Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype / Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tuechler, Heinz (Boltzmann Institute for Leukaemia Research and Hematology) ; Arenillas, Leonor (Hospital del Mar (Barcelona, Catalunya)) ; Raynaud, Sophie (Cote d'Azur University) ; Cluzeau, Thomas (Cote d'Azur University) ; Shih, Lee-Yung (Chang Gung University) ; Tung-Liang, Chiang (Chang Gung University) ; Ganster, Christina (University Medical Center Göttingen) ; Shirneshan, Katayoon (University Medical Center Göttingen) ; Haase, Detlef (University Medical Center Göttingen) ; Mascaró, Martí (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Palomo Sanchís, Laura (Vall d'Hebron Institut d'Oncologia) ; Cervera, José (Hospital Universitari i Politècnic La Fe (València)) ; Such, Esperanza (Hospital Universitari i Politècnic La Fe (València)) ; Trim, Nicola (Birmingham Women's Hospital) ; Jeffries, Sally (Birmingham Women's Hospital) ; Ridgway, Emma (Birmingham Women's Hospital) ; Marconi, Giovanni (IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori") ; Martinelli, Giovanni (IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori") ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Half of the myelodysplastic syndromes (MDS) have normal karyotype by conventional banding analysis. The percentage of true normal karyotype cases can be reduced by 20-30% with the complementary application of genomic microarrays. [...]
2023 - 10.1002/jha2.651
EJHaem, Vol. 4 (february 2023) , p. 446-449  
7.
14 p, 1.0 MB CD34 + CD19 − CD22 + B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies / Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Barrera, Susana (Universidad de Salamanca) ; Bataller, Alex (Hospital Clínic i Provincial de Barcelona) ; Ortiz-Maldonado, Valentín (Hospital Clínic i Provincial de Barcelona) ; Elliot, Natalina (John Radcliffe Hospital (Oxford, Regne Unit)) ; O'Byrne, Sorcha (John Radcliffe Hospital (Oxford, Regne Unit)) ; Wang, Guanlin (University of Oxford) ; Rovira, Montse (University of Oxford) ; Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Trincado Alonso, Juan Luis, 1987- (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; González-González, María (Universidad de Salamanca) ; Morgades, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sorigue, Marc (Universitat Autònoma de Barcelona) ; Bárcena, Paloma (Universidad de Salamanca) ; Zanetti, S. R (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Torrebadell, Montse (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Vega-Garcia, Nerea (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Rives, Susana (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Mallo, Maria del Mar (Universitat Autònoma de Barcelona) ; Sole, F (Universitat Autònoma de Barcelona) ; Mead, Adam J. (Centro Nacional de Investigaciones Oncológicas Carlos III (Espanya)) ; Roberts, Irene (Oxford Biomedical Research Centre) ; Thongjuea, Supat (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Psaila, Bethan (Oxford Biomedical Research Centre) ; Juan, Manel (Hospital Clínic i Provincial de Barcelona) ; Delgado, Julio (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Urbano-Ispizúa, Alvaro (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribera, Jose-Maria (Universitat Autònoma de Barcelona) ; Orfao, Alberto (Universidad de Salamanca) ; Roy, Anindita (Oxford Biomedical Research Centre) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Three article in this issue present preclinical data aimed at improving immunotherapeutic approaches for relapsed B- and T-cell acute lymphoblastic leukemia (T-ALL). Chimeric antigen receptor T (CAR-T) cell therapy directed against relapsed T-ALL is hampered by difficulty in identifying a target antigen that is not also expressed on healthy T cells, risking "fratricide" with T-cell aplasia and loss of the CAR-T cells. [...]
2022 - 10.1182/blood.2021014840
Blood, Vol. 140 (july 2022) , p. 38-44  
8.
14 p, 9.2 MB Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1 -Mutant Myelodysplastic Syndromes With Ringed Sideroblasts / Ademà, Vera (The University of Texas MD Anderson Cancer Center) ; Ma, Feiyang (University of Michigan) ; Kanagal-Shamanna, Rashmi (The University of Texas MD Anderson Cancer Center) ; Thongon, Natthakan (The University of Texas MD Anderson Cancer Center) ; Montalban-Bravo, Guillermo (The University of Texas) ; Yang, Hui (The University of Texas) ; Peslak, Scott A. (Children's Hospital of Philadelphia (Pennsilvània)) ; Wang, Feng (The University of Texas MD Anderson Cancer Center) ; Acha, Pamela (Universitat Autònoma de Barcelona) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Lockyer, Pamela (The University of Texas MD Anderson Cancer Center) ; Cassari, Margherita (University of Florence) ; Maciejewski, Jaroslaw P. (Cleveland Clinic Foundation) ; Visconte, Valeria (Cleveland Clinic Foundation) ; Gañán-Gómez, Irene (The University of Texas MD Anderson Cancer Center) ; Song, Yuanbin (Sun Yat-sen University Cancer Center) ; Bueso-Ramos, Carlos (The University of Texas MD Anderson Cancer Center) ; Pellegrini, Matteo (University of California) ; Tan, Tuyet M. (Univerity of California San Diego) ; Bejar, Rafael (Univerity of California San Diego) ; Carew, Jennifer S. (University of Arizona Cancer Center) ; Halene, Stephanie (Yale University School of Medicine) ; Santini, Valeria (University of Florence) ; Al-Atrash, Gheath (The University of Texas MD Anderson Cancer Center) ; Clise-Dwyer, Karen (The University of Texas MD Anderson Cancer Center) ; Garcia-Manero, Guillermo (The University of Texas MD Anderson Cancer Center) ; Blobel, Gerd A. (Children's Hospital of Philadelphia (Pennsilvània)) ; Colla, Simona (The University of Texas MD Anderson Cancer Center)
SF3B1 -mutant MDS-RS is associated with buildup of erythroid progenitor cells upregulating EIF2AK1-associated heme deficiency response and autophagy genes. Targeting EIF2AK1 relieves the dysregulated progenitor phenotype. [...]
2022 - 10.1158/2643-3230.BCD-21-0220
Blood Cancer Discovery, Vol. 3 (august 2022) , p. 554-567  
9.
13 p, 3.0 MB Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q / Ademà, Vera (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute) ; Palomo Sanchís, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Walter, Wencke (Munich Leukemia Laboratory) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hutter, Stephan (Munich Leukemia Laboratory) ; La Framboise, Thomas (Department of Genetics and Genome Sciences. Case Western Reserve University) ; Arenillas, Leonor (Institut Hospital del Mar d'Investigacions Mèdiques) ; Meggendorfer, Manja (Munich Leukemia Laboratory) ; Radivoyevitch, Tomas (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Pellagatti, Andrea (Blood Cancer UK Molecular Haematology Unit. Nuffield Division of Clinical Laboratory Sciences. Radcliffe Department of Medicine. University of Oxford and Oxford BRC Haematology Theme) ; Haferlach, Claudia (Munich Leukemia Laboratory) ; Boultwood, Jacqueline (University of Oxford. Radcliffe Department of Medicine) ; Kern, Wolfgang (Munich Leukemia Laboratory) ; Visconte, Valeria (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute) ; Sekeres, Mikkael (Leukemia Program. Department of Hematology and Medical Oncology. Cleveland Clinic. Cleveland Clinic Taussig Cancer Institute) ; Barnard, John (Department of Quantitative Health Sciences. Cleveland Clinic. Lerner Research Institute) ; Haferlach, Torsten (Munich Leukemia Laboratory) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Maciejewski, Jaroslaw (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute)
Background: Haploinsufficiency (HI) resulting from deletion of the long arm of chromosome 5 [del(5q)] and the accompanied loss of heterozygosity are likely key pathogenic factors in del(5q) myeloid neoplasia (MN) although the consequences of del(5q) have not been yet clarified. [...]
2022 - 10.1016/j.ebiom.2022.104059
EBioMedicine, Vol. 80 (june 2022) , art. 104059  
10.
12 p, 1.0 MB Guiding the global evolution of cytogenetic testing for hematologic malignancies / Akkari, Yassmine M.N. (Departments of Cytogenetics and Molecular Pathology. Legacy Health (Estats Units d'Amèrica)) ; Baughn, Linda B. (Mayo Clinic) ; Dubuc, Adrian M. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Smith, Adam C. (University of Toronto) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Dal Cin, Paola (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Diez-Campelo, María (Instituto de Investigación Biomédica de Salamanca) ; Gallego, Marta S. (Italian Hospital) ; Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Haase, Detlef (University Medical Center Göttingen) ; Schlegelberger, Brigitte (Department of Human Genetics. Hannover Medical School) ; Slavutsky, Irma (Institute of Experimental Medicine) ; Mecucci, Cristina (Hematology University of Perugia) ; Levine, Ross L. (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Hasserjian, Robert P. (Massachusetts General Hospital (Boston)) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Levy, Brynn (Columbia University Medical Center) ; Xu, Xinjie (Mayo Clinic) ; Universitat Autònoma de Barcelona
2022 - 10.1182/blood.2021014309
Blood, Vol. 139 Núm. 15 (14 2022) , p. 2273-2284  

Articles : 35 registres trobats   1 - 10següentfinal  anar al registre:
Llibres i col·leccions 2 registres trobats  
1.
14 p, 1.5 MB Els nous reptes del periodisme : fake news i big data / Duch Gavaldà, Jordi (Universitat Rovira i Virgili. Departament d'Enginyeria Informàtica i Matemàtiques) ; Guerrero Solé, Frederic (Universitat Pompeu Fabra. Departament de Comunicació)
Les darreres campanyes d'Obama i Trump als Estats Units han estat un exemple de com la política ha fet de les xarxes socials el seu espai de combat. L'anàlisi i l'explotació de dades massives (big data) s'han convertit en una eina fonamental per tal de prendre decisions determinants per influir en l'opinió pública i, finalment, en els resultats electorals. [...]
Barcelona: Generalitat de Catalunya, 2019 (Lexikon Informes; 6)
Informe de la comunicació a Catalunya, 2019, p. 303-316  
2.
13 p, 385.2 KB La Universidad y el desarrollo de la función empresarial / Solé Parellada, Francesc (Universitat Politècnica de Catalunya) ; Genescà i Garrigosa, Enric (Universitat Autònoma de Barcelona)
Alcalá de Henares : Asociación Científica de Economía y Dirección de la Empresa (ACEDE), 2017
ACEDE XXV años de historia. Evolución de la investigación en Economía y Dirección de la empresa en España, 2017, p. 221-233  

Documents de recerca 19 registres trobats  1 - 10següent  anar al registre:
1.
13 p, 280.5 KB D2.4 Co-design methodology evaluation / Fondazione scuola di pace di Monte Sole
The goal of this deliverable is to infer the evaluation of the co-creation methodology starting from the design of it, illustrated in D2. 3, and from the context and the premises of the So-Close project design and Consortium. [...]
2021 (SO-CLOSE)  
2.
24 p, 546.8 KB D2.3 Co-design methodology template / Fondazione scuola di Pace Monte Sole
The goal of this report is to illustrate the co-creation methodology as a natural consequence determined by the context and the premises of the SO-CLOSE project design and Consortium.
The text develops firstly an introduction as a short analytical report of the project framework, both in terms of scientific competences and interactional practices present in the Consortium and it turns then to a critic review of literature and experiences about co-creation. [...]

2021 (SO-CLOSE)  
3.
12 p, 432.8 KB WP2 : Co-design of the tools for cultural heritage co-creation / Universitat Autònoma de Barcelona ; Fondazione Scuola di Pace di Monte Sole
Training session. Main goals are A) to prepare cultural institutions for their task of conducting focus groups as part of WP2 and B) to start off the partners in their design of their respective focus group meetings. [...]
2020 (SO-CLOSE)
2 documents
4.
7 p, 290.8 KB D5.7-Policy Paper 2. Recommendations on policies to promote mutual understanding between refugees and the local communities in Europe / Monicelli, Elena (Fondazione Scuola de Pace di Monte Sole) ; Fondazione Scuola de Pace di Monte Sole
The deliverable develops the WP2 activities' findings into recommendations for policy makers, in order to enhance social cohesion, mutual undertanding and efeective integration between local communities and refugee / asylum seeker individuals and communities in terms of cultural heritage and historical and personal memories.
2021 (SO-CLOSE Policy paper ; 2)  
5.
233 p, 6.2 MB Potencial ús de la curcumina en el tractament de la Leucèmia Limfocítica Crònica / Bistué Rovira, Àngel ; Petriz, Jordi, dir. ; Solé Ristol, Francesc, dir. ; Allué Creus, Josep, dir.
La curcumina és un compost fenòlic present en el rizoma de la Curcuma longa, que ha estat extensament estudiat en diversos models de càncer, per les seves propietats proapoptòtiques, antiinflamatòries i quimiosensibilitzadores, entre d'altres. [...]
La curcumina es un compuesto fenólico presente en el rizoma de la Curcuma longa, que ha sido estudiado en varios modelos de cáncer, por sus propiedades proapoptóticas, antiinflamatorias y quimiosensibilizadoras, entre otras. [...]
Curcumin is a phenolic compound present in the rhizome of Curcuma longa, which has been extensively studied in various cancer models, for its proapoptotic, anti-inflammatory and chemosensitizing properties, among others. [...]

2020  
6.
97.0 MB Corpus Cadlaws / Sole-Mauri, Francina (Universitat Autònoma de Barcelona)
Cadlaws is built from Canadian legal documents. The corpus contains over 16 milions words in each language and it is composed of documents that are legally equivalent in both languages but not the result of a translation. [...]
Universitat Autònoma de Barcelona, 2021 - 10.5565/ddd.uab.cat/238990
5 documents
7.
57 p, 1.3 MB Análisis de Contenido de Redes Sociales de Pequeñas y Medianas Empresas del Sector Turístico / Carrillo Enríquez, Cecilia ; Guerrero Solé, Frederic, dir. ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
Participar activamente en las redes sociales es indispensable especialmente para las Pymes, que buscan posicionarse en la mente del consumidor, generar mejor comunicación y mayor alcance optimizando sus limitados recursos. [...]
Participar activament a xarxes socials és indispensable especialment per a les Pimes, que busquen posicionar-se en la ment del consumidor, generar millor comunicació i major abast optimitzant els seus limitats recursos. [...]

2019  
8.
1 p, 1.6 MB First experience with a new customed OpenArray™ pig intestine panel: evaluation of protein sources for piglets / González Solé, Francesc ; Universitat Autònoma de Barcelona. Facultat de Veterinària
2018
Grau en Veterinària [955]  
9.
173 p, 2.0 MB Caracterización genética de la leucemia mielomonocítica crónica de bajo riesgo citogenético / Palomo Sanchís, Laura ; Zamora, Lurdes, dir. ; Solé Ristol, Francisco, dir. ; Ponte Marull, Immaculada, dir. ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
La leucemia mielomonocítica crónica (L12C) es una entidad que presenta una gran heterogeneidad a nivel clínico, morfológico y genético. El 70-75% de los pacientes con L12C presenta un cariotipo normal al diagnóstico y hasta el 80% de los pacientes se clasifica en el grupo citogenético de bajo riesgo (cariotipo normal o pérdida aislada del cromosoma Y). [...]
La leucemia mielomonocítica crónica (LMMC) es una entidad que presenta una gran heterogeneidad a nivel clínico, morfológico y genético. El 70-75% de los pacientes con LMMC presenta un cariotipo normal al diagnóstico y hasta el 80% de los pacientes se clasifica en el grupo citogenético de bajo riesgo (cariotipo normal o pérdida aislada del cromosoma Y). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
10.
277 p, 4.1 MB Estudio de perfiles moleculares en pacientes con síndrome mielodisplásico / Ademà, Vera ; Barrios, Leonardo, tut. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Solé Ristol, Francisco, dir. ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Los SÍNDROMES MIELODISPLÁSICOS (SMD) son una enfermedad heterogénea clonal de células madre hematopoyéticas. Se caracteriza por una medula ósea ineficaz que produce citopenias en sangre periférica. [...]
MYELODYSPLASTIC SYNDROMES are clonal hematopoietic stem cell disorders highly heterogeneous. This disease is characterized by bone marrow failure that led to peripheral blood citopenias. The outcome of these patients is closely related to cytopenias and to an increased risk to acute myeloid leukemia (AML) progression. [...]

[Bellaterra] : Universitat Autònoma de Barcelona, 2016  

Documents de recerca : 19 registres trobats   1 - 10següent  anar al registre:
Vegeu també: autors amb noms similars
2 Sole, F,
11 Sole, F.
11 Solé, F.
1 Solé, Francisco
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.